Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration

被引:26
作者
Fasulo, WH
Hemby, SE
机构
[1] Emory Univ, Sch Med, Div Neurosci, Yerkes Natl Primate Res Ctr,Dept Pharmacol, Atlanta, GA 30329 USA
[2] Emory Univ, Sch Med, Div Neurosci,Dept Psychiat Behav Sci, Yerkes Natl Primate Res Ctr, Atlanta, GA USA
关键词
glutamate receptors; haloperidol; laser capture microdissection; single cell gene expression; substantia nigra; ventral tegmental area;
D O I
10.1046/j.1471-4159.2003.01986.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antipsychotic drugs require a treatment regimen of several weeks before clinical efficacy is achieved in patient populations. While the biochemical mechanisms underlying the delayed temporal profile remain unclear, molecular adaptations in specific neuroanatomical loci are likely involved. Haloperidol-induced changes in gene expression in various brain regions have been observed; however, alterations in distinct neuronal populations have remained elusive. The present study examined changes in gene expression profiles of ventral tegmental area (VTA) and substantia nigra (SN) tyrosine hydroxylase immunopositive neurons following 1, 10 or 21 days of haloperidol administration (0.5 mg/kg/day). Macroarrays were used to study the expression of receptors, signaling proteins, transcription factors and pre- and postsynaptic proteins. Data were analyzed using conventional statistical procedures as well as self-organizing maps (SOM) to elucidate conserved patterns of expression changes. Results show statistically significant haloperidol-induced and time-dependent alterations in 17 genes in the VTA and 25 genes in the SN, including glutamate and GABA receptor subunits, signaling proteins and transcription factors. SOMs revealed distinct patterns of gene expression changes in response to haloperidol. Understanding how gene expression is altered over a clinically relevant time course of haloperidol administration may provide insight into the development of antipsychotic efficacy as well as the underlying pathology of schizophrenia.
引用
收藏
页码:205 / 219
页数:15
相关论文
共 82 条
  • [1] Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice
    Adams, MR
    Brandon, EP
    Chartoff, EH
    Idzerda, RL
    Dorsa, DM
    McKnight, GS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12157 - 12161
  • [2] [Anonymous], 2000, SELF ORG MAPS
  • [3] NEUROLEPTIC ANTIPSYCHOTIC-DRUGS .2. NEUROLOGIC SIDE-EFFECTS
    BALDESSARINI, RJ
    [J]. POSTGRADUATE MEDICINE, 1979, 65 (04) : 123 - 128
  • [4] DOPAMINE AND THE PATHO-PHYSIOLOGY OF DYSKINESIAS INDUCED BY ANTIPSYCHOTIC-DRUGS
    BALDESSARINI, RJ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1980, 3 : 23 - 41
  • [5] BALDESSARINI RJ, 1979, POSTGRAD MED, V65, P114
  • [6] Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine
    Boye, SM
    Rompré, PP
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (03) : 1229 - 1239
  • [7] COLOCALIZATION OF TYROSINE-HYDROXYLASE AND GLUTAMATE-DECARBOXYLASE IN A SUBPOPULATION OF SINGLE NIGROTECTAL PROJECTION NEURONS
    CAMPBELL, KJ
    TAKADA, M
    HATTORI, T
    [J]. BRAIN RESEARCH, 1991, 558 (02) : 239 - 244
  • [8] A glutamatergic deficiency model of schizophrenia
    Carlsson, A
    Hansson, LO
    Waters, N
    Carlsson, ML
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 2 - 6
  • [9] Expression profile and up-regulation of Prax-1 mRNA by antidepressant treatment in the rat brain
    Chardenot, P
    Roubert, C
    Galiègue, S
    Casellas, P
    Le Fur, G
    Soubrié, P
    Oury-Donat, F
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (06) : 1314 - 1320
  • [10] CHIODO LA, 1987, J NEUROSCI, V7, P629